H.R. 7528

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7528 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 7528

To amend section 503B of the Federal Food, Drug, and Cosmetic Act to 
enhance the ability of outsourcing facilities to mitigate drug 
shortages by allowing a short-term period to continue supplying the 
market after a drug is in shortage.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

February 12, 2026

Mr. Carter of Georgia introduced the following bill; which was referred 
to the Committee on Energy and Commerce

_______________________________________________________________________

A BILL

To amend section 503B of the Federal Food, Drug, and Cosmetic Act to 
enhance the ability of outsourcing facilities to mitigate drug 
shortages by allowing a short-term period to continue supplying the 
market after a drug is in shortage.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Growing America's Pharmaceutical 
Supply Act'' or the ``GAP Supply Act''.

SEC. 2. PROVIDING FOR A TAIL PERIOD FOR OUTSOURCING FACILITIES TO 
COMPOUND AND DISTRIBUTE DRUGS IN SHORTAGE.

Section 503B of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
353b) is amended--
(1) in subsection (a)(2)(A)(ii), by striking ``at the 
time'' and inserting ``within 180 calendar days''; and
(2) in subsection (d)(2)(A), by striking ``at the time'' 
and inserting ``within 180 calendar days''.
<all>